Astellas Pharma Inc. (ALPMY)

PNK: ALPMY · Real-Time Price · USD

10.04

0.13 (1.31%)

At close: May 02, 2025, 2:33 PM

Astellas Pharma Cash Flow Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Net Income	17.05B	98.71B	124.09B	120.59B	195.41B	222.26B	164.68B	218.7B	193.69B
Depreciation & Amortization	157.84B	105.74B	79.68B	72.65B	66.4B	63.46B	64.86B	63.79B	69.19B
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	n/a	98.19B	-16.64B	47.39B	-10.4B	20M	69.72B	-27.41B	136.58B
Other Non-Cash Items	84.11B	53.89B	65.07B	98.98B	16.45B	83.19B	170.14B	121.6B	175.28B
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-86.52B	73.98B	-10.68B	15.66B	-54.19B	9.73B	57.12B	-33.34B	76.67B
Operating Cash Flow	172.47B	332.32B	258.16B	307.88B	224.06B	261.43B	314.46B	237.23B	316.53B
Capital Expenditures	-82.5B	-88.54B	-76.45B	-77.44B	-77.89B	-52.13B	-40.28B	-48.65B	-118.12B
Cash Acquisitions	-784.97B	n/a	-229M	-8.09B	-313.84B	1.66B	-82.51B	-49.65B	-40.9B
Purchase of Investments	n/a	n/a	-5.58B	n/a	n/a	n/a	-693M	-484M	-749M
Sales Maturities Of Investments	n/a	12.62B	5.58B	n/a	n/a	n/a	6.97B	28.64B	16.75B
Other Investing Acitivies	-22.77B	-13.14B	13.55B	2.6B	-127M	5.92B	-7.13B	-4.86B	-6.83B
Investing Cash Flow	-845.8B	-89.06B	-63.13B	-82.93B	-391.86B	-44.55B	-123.65B	-75B	-149.85B
Debt Repayment	771.23B	-15B	-60B	-126B	326B	n/a	n/a	n/a	n/a
Common Stock Repurchased	-10.73B	-60.56B	-50.72B	-9.16B	-52.9B	-160.44B	-130.71B	-92.19B	-120.13B
Dividend Paid	-116.65B	-100.36B	-85.24B	-76.16B	-73.54B	-72.07B	-71.63B	-70.12B	-69.61B
Other Financial Acitivies	-29.79B	-19.71B	-20.34B	-18.16B	-18.51B	-1.17B	-1.08B	-3.84B	-3.74B
Financial Cash Flow	614.06B	-195.62B	-216.3B	-229.48B	181.06B	-233.68B	-203.43B	-166.15B	-193.48B
Net Cash Flow	-41.15B	60.85B	-10.14B	7.74B	7.32B	-20.66B	-9.19B	-19.11B	-36.4B
Free Cash Flow	89.98B	243.78B	181.71B	230.44B	146.17B	209.3B	274.18B	188.58B	198.42B